Primary Site >> Colorectal Cancer

Gene >> OXCT1

  • 2016
  • 2018
Ref: Discovery of genes from feces correlated with colorectal cancer progression.
PMID: 27900008
Ref: 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
PMID: 29611518
Ref: Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients.
PMID: 30155352